Market Research Report
Australia Dental Implants Market Analysis - COVID19 - 2021-2027 - MedSuite - Includes: Dental Implants, Final Abutments & Surgical Guides
|Published by||iData Research Inc.||Product code||1000921|
|Published||Content info||195 Pages
Delivery time: 1-2 business days
|Australia Dental Implants Market Analysis - COVID19 - 2021-2027 - MedSuite - Includes: Dental Implants, Final Abutments & Surgical Guides|
|Published: January 19, 2021||Content info: 195 Pages||
Throughout this medical market research, the publisher analyzed 21 dental implant companies in Australia and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.
While this MedSuite report contains all of the Australian Dental Implants Market analysis, each of the market segments is also available for purchase as a stand-alone report, MedCore.
Dental Implant Market - MedCore
Final Abutment Market - MedCore
Surgical Guide Market - MedCore
Australia Dental Implants Market Insights
Overall, the Australia dental Implant and final abutment market was valued at $76.7 million in 2020. This is expected to increase over the forecast period at a CAGR of 8.6% to reach $136.4 million in 2027.
An ongoing trend within the dental implant market is the increasing movement towards digitization, resulting in high growth of the CAD/CAM abutment market. Through the use of CAD/CAM technology, dentists and laboratory technicians are able to increase productivity levels. Prices for CAD/CAM systems and materials are expected to gradually decrease throughout the forecast period, so more laboratories and dental clinics will be able to invest in the technology.
Nobel Biocare, which operates under the Envista family of companies, occupied the leading position in the Australian dental implant and final abutment market in 2020. The company excels across the entire dental sector in Australia but will face competitive pressure going forward. Nevertheless, the entire range of products under NobelActive® continued to perform well.